Sumitomo Pharma Co., Ltd. (TYO:4506)

Japan flag Japan · Delayed Price · Currency is JPY
747.00
+9.00 (1.22%)
Mar 28, 2025, 3:30 PM JST
85.36%
Market Cap 296.78B
Revenue (ttm) 372.71B
Net Income (ttm) -176.04B
Shares Out 397.29M
EPS (ttm) -443.11
PE Ratio n/a
Forward PE 19.63
Dividend n/a
Ex-Dividend Date n/a
Volume 1,507,500
Average Volume 1,874,425
Open 748.00
Previous Close 738.00
Day's Range 738.00 - 756.00
52-Week Range 279.00 - 838.00
Beta 0.56
RSI 61.33
Earnings Date May 13, 2025

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson’s disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It provides products for atypical anti... [Read more]

Sector Healthcare
Founded 1897
Employees 4,980
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4506
Full Company Profile

Financial Performance

In 2023, Sumitomo Pharma's revenue was 314.56 billion, a decrease of -43.38% compared to the previous year's 555.54 billion. Losses were -314.97 billion, 322.7% more than in 2022.

Financial Statements

News

There is no news available yet.